IFNA1 and systemic lupus erythematosus: As Simoa IFN-α assessment seems to be relevant for monitoring disease activity in the blood and CSF of (j)-(NP)SLE patients, we believe that it would have value as a routine test in (j)-SLE and (j)-NPSLE.